These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6542602)
41. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy. Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424 [TBL] [Abstract][Full Text] [Related]
42. Progression of hypertrophic into a dilated left ventricle in Friedreich's ataxia. Casazza F; Morpurgo M G Ital Cardiol; 1988 Jul; 18(7):615-8. PubMed ID: 3234661 [TBL] [Abstract][Full Text] [Related]
43. [Novacor installation in a case of severe heart failure at the terminal stage caused by dilated hypertrophic cardiomyopathy]. Nushimura M Kyobu Geka; 2012 Sep; 65(10):880. PubMed ID: 23189761 [No Abstract] [Full Text] [Related]
51. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy. Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637 [TBL] [Abstract][Full Text] [Related]
52. [Anesthetic management of patients with cardiomyopathies]. Takenaka T; Nomiyama S; Okada S; Miyoshi S; Murakami M; Watanabe S; Tanaka R Masui; 1990 May; 39(5):644-50. PubMed ID: 2384960 [TBL] [Abstract][Full Text] [Related]
53. Hypertrophic cardiomyopathy evolving into a hypokinetic and dilated left ventricle: coronary embolization as a probable pathogenetic mechanism. Gravanis MB; Robinson PH; Hertzler GL Clin Cardiol; 1990 Jul; 13(7):500-5. PubMed ID: 2364585 [TBL] [Abstract][Full Text] [Related]
54. The feasibility of left ventricular mechanical support as a bridge to cardiac recovery. Liden H; Karason K; Bergh CH; Nilsson F; Koul B; Wiklund L Eur J Heart Fail; 2007 May; 9(5):525-30. PubMed ID: 17257894 [TBL] [Abstract][Full Text] [Related]
55. Possibilities of two-dimensional echocardiography in cardiomyopathies. Gregor P; Widimský P; Cervenka V; Sládková T; Vísek V Cor Vasa; 1984; 26(1):20-6. PubMed ID: 6539193 [TBL] [Abstract][Full Text] [Related]
56. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989 [TBL] [Abstract][Full Text] [Related]
57. Response to isoproterenol as a prognostic indicator of evolution from hypertrophic cardiomyopathy to a phase resembling dilated cardiomyopathy. Kawano S; Iida K; Fujieda K; Yukisada K; Magdi ES; Iwasaki Y; Tabei F; Yamaguchi I; Sugishita Y J Am Coll Cardiol; 1995 Mar; 25(3):687-92. PubMed ID: 7860914 [TBL] [Abstract][Full Text] [Related]
58. [Apical hypertrophic cardiomyopathy as a cause of cardiac insufficiency in an 84-year-old woman--a case report]. Grabysa R Kardiol Pol; 2008 Feb; 66(2):179-82. PubMed ID: 18344156 [TBL] [Abstract][Full Text] [Related]
59. Predictors of death from congestive heart failure in hypertrophic cardiomyopathy. Ikeda H; Maki S; Yoshida N; Murohara T; Adachi H; Koga Y; Imaizumi T Am J Cardiol; 1999 Apr; 83(8):1280-3, A9. PubMed ID: 10215301 [TBL] [Abstract][Full Text] [Related]
60. Relationship between the QT indices and the microvolt-level T wave alternans in cardiomyopathy. Kuroda N; Ohnishi Y; Adachi K; Yokoyama M Jpn Circ J; 2001 Nov; 65(11):974-8. PubMed ID: 11716250 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]